Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Radiation Injuries 2Medulloblastoma 2Fatigue 2Choroid Plexus Neoplasms 2Breast Neoplasms 2Astrocytoma 2Spinal Cord Neoplasms 1Sleep Wake Disorders 1Pinealoma 1Pain 1Optic Nerve Glioma 1Oligodendroglioma 1Neurotoxicity Syndromes 1Neuroectodermal Tumors, Primitive 1Neoplasms 1Neoplasm Metastasis 1Meningioma 1Memory Disorders 1Gliosarcoma 1Glioma, Subependymal 1Glioma 1Glioblastoma 1Familial ependymoma 1Ependymoma 1Depression 1Craniopharyngioma 1Cognitive Dysfunction 1Cognition Disorders 1Central Nervous System Neoplasms 1Cancer Pain 1

Interventions

Exenatide 2antineoplaston AS 2-1 1antineoplaston A10 1Radiotherapy, Image-Guided 1Oxytocin 1Fentanyl 1Donepezil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Craniopharyngioma × Donepezil × Clear all
NCT00369785 2021-10-20

Donepezil in Treating Patients Who Have Undergone Radiation Therapy for Brain Tumors

Wake Forest University Health Sciences

Phase 3 Completed
198 enrolled 10 charts
CNSSarcoma

Astrocytoma, Brain Neoplasms, Craniopharyngioma, Ependymoma, Fatigue, Glioblastoma, Glioma, Medulloblastoma, Meningioma, Neoplasm Metastasis, Oligodendroglioma, Pinealoma, Radiation Injuries, Choroid Plexus Neoplasms, Neuroectodermal Tumors, Primitive, Glioma, Subependymal, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡